Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit
Vidéo sur ASMD en 4 min

Vidéo sur ASMD en 4 min

Niemann-Pick: Comprendre le déficit en sphingomyélinase acide en 4 minutes

BRIGHT publication

BRIGHT publication

The Bright study demonstrated similar efficacy and safety of Toujeo® (Glargine 300) compared to degludec (insulin degludec) in type 2 diabetes patients who had not previously received basal insulin1.

BRIGHT publication

BRIGHT publication

The Bright study demonstrated similar efficacy and safety of Toujeo® (Glargine 300 U/ml) compared to degludec 100 U/ml in type 2 diabetes patients who had not previously received basal insulin1.

BRIGHT publication

BRIGHT publication

ATS 2025 Scientific Highlights

ATS 2025 Scientific Highlights

May 17–21, 2025; San Francisco, California, US

ATS 2025 Scientific Highlights

ATS 2025 Scientific Highlights

May 17–21, 2025; San Francisco, California, US

ATS 2025 Scientific Highlights

ATS 2025 Scientific Highlights

May 17–21, 2025; San Francisco, California, US

What's New in Pediatric Atopic Dermatitis?

What's New in Pediatric Atopic Dermatitis?

What's New in Pediatric Atopic Dermatitis?

What's New in Pediatric Atopic Dermatitis?

Real World Evidence Grafik Beyfortus®

Real World Evidence Grafik Beyfortus®

Assessment of predictors for cancer-associated VTE recurrence after discontinuation of anticoagulant therapy: A multicenter cohort study

Assessment of predictors for cancer-associated VTE recurrence after discontinuation of anticoagulant therapy: A multicenter cohort study

Plusprint RSV

Plusprint RSV